Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression
Anticancer Research · 2024
DOI: 10.21873/anticanres.17090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2024. Verfasst von Yusuke Aoki und 7 weiteren Autor:innen. Beteiligte Einrichtung: AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com. Hauptthemen laut MEDLINE: Osteosarcoma, Methotrexate, Tetrahydrofolate Dehydrogenase, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- AntiCancer Inc, San Diego, CA, U.S.A.; yaoki0630@gmail.com.
- Department of Surgery, University of California, San Diego, La Jolla, CA, U.S.A.
- Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
- AntiCancer Inc, San Diego, CA, U.S.A.
- Department of Orthopedic Surgery, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan yastome@med.u-ryukyu.ac.jp.
- AntiCancer Inc, San Diego, CA, U.S.A.; all@anticancer.com.
Zitieren
APA
Aoki, Y., Kubota, Y., Masaki, N., Obara, K., Tome, Y., Bouvet, M., Nishida, K., & Hoffman, R. M. (2024). Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression. Anticancer Research. https://doi.org/10.21873/anticanres.17090
Vancouver
Aoki Y, Kubota Y, Masaki N, Obara K, Tome Y, Bouvet M, et al. Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression. Anticancer Research. 2024. doi:10.21873/anticanres.17090
BibTeX
@article{Aoki2024,
author = {Aoki, Yusuke and Kubota, Yutaro and Masaki, Noriyuki and Obara, Koya and Tome, Yasunori and Bouvet, Michael and Nishida, Kotaro and Hoffman, Robert M},
title = {Reduced Malignancy of Super Methotrexate-resistant Osteosarcoma Cells With Dihydrofolate Reductase Amplification Despite Paradoxical Gain of Oncogenic PI3K/AKT/mTOR and c-MYC expression},
journal = {Anticancer Research},
year = {2024},
doi = {10.21873/anticanres.17090}
}
EUVIMED